Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective
- 1 March 2004
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 33 (8) , 815-821
- https://doi.org/10.1038/sj.bmt.1704444
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow TransplantationJournal of Clinical Oncology, 2001
- Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplantsBone Marrow Transplantation, 1997
- Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patientsBone Marrow Transplantation, 1997
- Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapyBone Marrow Transplantation, 1997
- Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effectLeukemia, 1997
- Graft-versus-myeloma effect in two casesThe Lancet, 1996
- Graft-versus-Leukemia Effect and Its Clinical ImplicationsLeukemia & Lymphoma, 1996
- The Graft-vs.-Leukemia EffectJournal of Pediatric Hematology/Oncology, 1993
- Treatment of childhood acute lymphoblastic leukaemia: Present issues and future prospectsBlood Reviews, 1992
- Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A REPORT BY THE EBMT LEUKAEMIA WORKING PARTYBritish Journal of Haematology, 1991